Venus Remedies has secured Marketing Authorization for Pemetrexed 500 mg, a chemotherapeutic agent widely used in the treatment of lung cancer and mesothelioma, in the Philippines. This authorization marks a significant milestone in the company's journey to strengthen its presence in the high-growth Southeast Asian pharmaceutical market.
Venus Remedies is one of the handful player in pharmaceutical sector to launch world global injectable manufacturers.